Table 1.
Comparison of clinical characteristics
| Carperitide group | Non-carperitide group | p value | |
|---|---|---|---|
| Number | 63 | 65 | |
| Age (years) | 65.4 ± 9.4 | 67.2 ± 8.2 | 0.254 |
| >75 years | 11 (17%) | 14 (22%) | 0.561 |
| Gender (male: female) | 49:14 | 44:21 | 0.201 |
| Body surface area (m2) | 1.60 ± 0.16 | 1.54 ± 0.16 | 0.06 |
| Diagnosis | 0.671 | ||
| IHD | 43 | 41 | |
| Valvular disease | 4 | 15 | |
| Aortic disease | 0 | 3 | |
| IHD + valve | 12 | 6 | |
| Valve + aorta | 1 | 0 | |
| Cause of CKD | 0.186 | ||
| Diabetic nephropathy | 47 | 41 | |
| Chronic glomerulonephritis | 11 | 21 | |
| Nephrosclerosis | 2 | 2 | |
| Others | 3 | 1 | |
| Anuria | 39 | 50 | 0.065 |
| Oliguria | 24 | 15 | |
| Emergency or urgent | 12 (19%) | 19 (29%) | 0.179 |
| Re-operation | 1 (2%) | 2 (3%) | 0.578 |
| Risk factors | |||
| Diabetes mellitus | 42 (67%) | 40 (62%) | 0.545 |
| Hypertension | 55 (87%) | 52 (80%) | 0.265 |
| Dyslipidemia | 21 (33%) | 17 (26%) | 0.374 |
| Obesity | 18 (29%) | 8 (12%) | 0.022 |
| Smoking | 23 (37%) | 22 (34%) | 0.752 |
| LV dysfunction | 20 (32%) | 19 (29%) | 0.757 |
| COPD | 3 (5%) | 0 (0%) | 0.075 |
| Cerebrovascular disease | 2 (3%) | 5 (8%) | 0.261 |
| PAD | 19 (30%) | 16 (25%) | 0.482 |
| Previous PCI | 11 (17%) | 13 (20%) | 0.713 |
| Ejection fraction (%) | 51.6 ± 14.7 | 51.5 ±14.3 | 0.891 |
| Duration of HD (years) | 6.23 ± 3.86 | 6.97 ±4.73 | 0.251 |
IHD: ischemic heart disease; CKD: chronic kidney disease; LV: left ventricular; COPD: chronic obstructive pulmonary disease; PAD: peripheral artery disease; PCI: percutaneous coronary intervention; HD: hemodialysis